Lucid Diagnostics (LUCD) Notes Payables (2023 - 2026)

Lucid Diagnostics (LUCD) has 4 years of Notes Payables data on file, last reported at $25.2 million in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables fell 23.17% year-over-year to $25.2 million; the trailing twelve-month figure through Mar 2026 stood at $25.2 million (down 23.17% YoY), and the FY2025 full-year result was $24.0 million, up 29.03% from the prior year.
• Notes Payables for Q1 2026 stood at $25.2 million, up from $24.0 million in the prior quarter.
• Across five years, Notes Payables topped out at $32.8 million in Q1 2025 and bottomed at $10.2 million in Q3 2024.
• The 4-year median for Notes Payables is $14.5 million (2023), against an average of $18.1 million.
• The widest annual swing landed in 2024, when Notes Payables fell 29.61%; it then jumped 149.62% in 2025.
• A 4-year view of Notes Payables shows it stood at $14.0 million in 2023, then surged by 33.33% to $18.6 million in 2024, then grew by 29.03% to $24.0 million in 2025, then advanced by 5.0% to $25.2 million in 2026.
• The last three Notes Payables figures came in at $25.2 million (Q1 2026), $24.0 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.

Peer Comparison